AlphaCentric Advisors’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
TCM
FLAM
BBA
5VM
B
VPC
AlphaCentric Advisors's TECX Position: Q2 2026 in Review
AlphaCentric Advisors increased its Tectonic Therapeutic (TECX) stake by 1.4% in Q2 2026, buying an estimated $2.91K and bringing the position to 6,948 shares worth $239K. The position accounts for 0.2% of the portfolio, ranked #150.
AlphaCentric Advisors first reported a position in TECX in Q4 2020 and has held it in 4 quarters since. The position peaked at $247K in Q4 2020. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.
- AlphaCentric Advisors held 6,948 shares of Tectonic Therapeutic worth $239K as of Q2 2026.
- AlphaCentric Advisors bought 99 Tectonic Therapeutic shares in Q2 2026, an estimated $2.91K.
- Tectonic Therapeutic made up 0.2% of AlphaCentric Advisors's portfolio in Q2 2026, its #150 holding.
- AlphaCentric Advisors first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 4 quarters since.
- AlphaCentric Advisors's Tectonic Therapeutic position peaked at $247K in Q4 2020.
- 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.
Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.